YMAB

Stock ticker: NASDAQ

PRICE

CHANGE

CAPITALIZATION

Y-mAbs Therapeutics (YMAB) Earnings Date & Reports

Y-mAbs Therapeutics Inc is a commercial-stage biopharmaceutical company... Show more

Industry: #Pharmaceuticals Major

Get AI intraday signals

A.I. Advisor

published Earnings

YMAB is expected to report earnings to rise 27.40% to -19 cents per share on May 12

Y-mAbs Therapeutics YMAB Stock Earnings Reports

Q1'25

Est.

$-0.19

Q4'24

Missed

by $0.03

Q3'24

Missed

by $0.01

Q2'24

Missed

by $0.09

Q1'24

Missed

by $0.01

The last earnings report on March 04 showed earnings per share of -15 cents, missing the estimate of -11 cents. With 238.83K shares outstanding, the current market capitalization sits at 217.05M.

View a ticker or compare two or three

Compare

YMAB

Setup

Buy or SellView

Daily Signalchanged days ago

Gain/Loss if bought

View Trends For YMAB
(Try 14 days for Free)

Ad is loading...

A.I.Advisor

published price charts

View to see Real Time Patterns for YMAB (Try 14 days for Free)

A.I. Advisor

published General Information

General Information

a developer of novel antibody therapeutics for oncology targets

Industry Biotechnology

Profile

Fundamentals

Details

Industry

Pharmaceuticals Major

Address

230 Park Avenue

Phone

+1 646 885-8505

Employees

100

Web

https://www.ymabs.com